SEC Form 4 · accession 0001645627-18-000075
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2018 | P | 2,000 | $0.029 | A | 26,219,498 | D | |
| Common Stock | Nov 27, 2018 | P | 2,000 | $0.0289 | A | 26,221,498 | D | |
| Common Stock | Nov 27, 2018 | P | 1,000 | $0.029 | A | 26,222,498 | D | |
| Common Stock | Nov 27, 2018 | P | 1,000 | $0.029 | A | 26,223,498 | D | |
| Common Stock | Nov 27, 2018 | P | 2,500 | $0.029 | A | 26,225,998 | D | |
| Common Stock | Nov 27, 2018 | P | 2,500 | $0.029 | A | 26,228,498 | D | |
| Common Stock | Nov 27, 2018 | P | 2,500 | $0.029 | A | 26,230,998 | D | |
| Common Stock | Nov 27, 2018 | P | 2,500 | $0.029 | A | 26,233,498 | D | |
| Common Stock | Nov 27, 2018 | P | 2,500 | $0.0287 | A | 26,235,998 | D | |
| Common Stock | Nov 27, 2018 | P | 5,000 | $0.0287 | A | 26,240,998 | D | |
| Common Stock | Nov 27, 2018 | P | 2,000 | $0.029 | A | 26,242,998 | D | |
| Common Stock | Nov 27, 2018 | P | 2,000 | $0.0287 | A | 26,244,998 | D | |
| Common Stock | Nov 28, 2018 | P | 5,000 | $0.0284 | A | 26,249,998 | D | |
| Common Stock | Nov 28, 2018 | P | 1,000 | $0.0284 | A | 26,250,998 | D | |
| Common Stock | Nov 28, 2018 | P | 1,000 | $0.0285 | A | 26,251,998 | D | |
| Common Stock | Nov 28, 2018 | P | 1,000 | $0.0282 | A | 26,252,998 | D |
Table II — derivative securities
No Table II lines on this filing.